RP
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
12.655
Exchange
XNAS - Nasdaq
0.66 B
Last period CFO ,USD
What is CFO ?
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
See also Royalty Pharma
Company Analysis
RPRX valuation, rating, competitors, insights and company profile
Eyestock Rating
RPRX financial analysis by Eyestock methodology
Valuation
RPRX valuation using historical relative method
Statements
RPRX Income Statements, Balance Sheet and Cash Flow Statements
Dividends
RPRX dividend yield and annual dividend
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
Royalty Pharma`s CFO for the period ended 2024-06-30 is 0.66 B USD
